BIONET Therapeutics Corp. (TPEX:7808)

BIONET Therapeutics Statistics

Total Valuation

TPEX:7808 has a market cap or net worth of TWD 3.31 billion. The enterprise value is 2.26 billion.

Market Cap	3.31B
Enterprise Value	2.26B

Important Dates

The last earnings date was Thursday, April 2, 2026.

Earnings Date	Apr 2, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:7808 has 70.00 million shares outstanding. The number of shares has increased by 21.89% in one year.

Current Share Class	70.00M
Shares Outstanding	70.00M
Shares Change (YoY)	+21.89%
Shares Change (QoQ)	+7.66%
Owned by Insiders (%)	4.46%
Owned by Institutions (%)	1.91%
Float	36.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.41
PB Ratio	2.72
P/TBV Ratio	2.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.18
EV / Sales	14.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.29

Financial Position

The company has a current ratio of 19.70, with a Debt / Equity ratio of 0.01.

Current Ratio	19.70
Quick Ratio	18.97
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-1,437.60

Financial Efficiency

Return on equity (ROE) is -7.76% and return on invested capital (ROIC) is -5.77%.

Return on Equity (ROE)	-7.76%
Return on Assets (ROA)	-5.53%
Return on Invested Capital (ROIC)	-5.77%
Return on Capital Employed (ROCE)	-9.50%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.12M
Profits Per Employee	-1.33M
Employee Count	73
Asset Turnover	0.12
Inventory Turnover	3.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+9.50%
50-Day Moving Average	48.03
200-Day Moving Average	52.51
Relative Strength Index (RSI)	58.80
Average Volume (20 Days)	15,446

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:7808 had revenue of TWD 154.48 million and -97.43 million in losses. Loss per share was -1.39.

Revenue	154.48M
Gross Profit	61.65M
Operating Income	-116.45M
Pretax Income	-97.43M
Net Income	-97.43M
EBITDA	-104.68M
EBIT	-116.45M
Loss Per Share	-1.39

Balance Sheet

The company has 1.06 billion in cash and 10.90 million in debt, with a net cash position of 1.05 billion or 14.99 per share.

Cash & Cash Equivalents	1.06B
Total Debt	10.90M
Net Cash	1.05B
Net Cash Per Share	14.99
Equity (Book Value)	1.22B
Book Value Per Share	17.32
Working Capital	1.08B

Cash Flow

In the last 12 months, operating cash flow was -57.48 million and capital expenditures -81.19 million, giving a free cash flow of -138.68 million.

Operating Cash Flow	-57.48M
Capital Expenditures	-81.19M
Depreciation & Amortization	11.77M
Net Borrowing	-713,000
Free Cash Flow	-138.68M
FCF Per Share	-1.98

Margins

Gross margin is 39.91%, with operating and profit margins of -75.38% and -63.07%.

Gross Margin	39.91%
Operating Margin	-75.38%
Pretax Margin	-63.07%
Profit Margin	-63.07%
EBITDA Margin	-67.76%
EBIT Margin	-75.38%
FCF Margin	n/a

Dividends & Yields

TPEX:7808 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.89%
Shareholder Yield	-21.89%
Earnings Yield	-2.95%
FCF Yield	-4.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3